Although the association of sex with immunotherapy effectiveness has been examined in multiple meta-analyses, none has tested this hypothesis specifically for patients with advanced melanoma receiving anti–PD-1 therapy or combination therapy, to our knowledge. Here, PDCD1 is linked to melanoma.